首页> 外国专利> USE OF AKT3 NUCLEIC ACIDS FOR THE MANUFACTURE OF A MEDICAMENT FOR INHIBITING CELL DEATH, TREATING MYOCARDIAL INFARCTION OR ISCHEMIA REPERFUSION INJURY

USE OF AKT3 NUCLEIC ACIDS FOR THE MANUFACTURE OF A MEDICAMENT FOR INHIBITING CELL DEATH, TREATING MYOCARDIAL INFARCTION OR ISCHEMIA REPERFUSION INJURY

机译：AKT3核酸在制造用于抑制细胞死亡，治疗心肌梗塞或缺血再灌注损伤的药物中的用途

页面导航

摘要
著录项
相似文献

摘要

The present invention relates to human Akt3 proteins and polypeptides. The invention also relates to isolated nucleic acids encoding human Akt3, to vectors containing them and to their therapeutic uses, in particular for gene therapy. Expression of Akt3 inhibits cell death associated with hypoxia, apoptosis or necrosis.

机译：本发明涉及人Akt3蛋白和多肽。本发明还涉及编码人Akt3的分离的核酸，涉及包含它们的载体及其治疗用途，特别是用于基因治疗。 Akt3的表达抑制与缺氧，凋亡或坏死有关的细胞死亡。

著录项

公开/公告号IL190270B

专利类型
公开/公告日2012-12-31

原文格式PDF
申请/专利权人 AVENTIS PHARMACEUTICALS INC.;
展开▼

申请/专利号IL190270
发明设计人
展开▼

申请日2008-03-18
分类号G01N33/50;A61K9/127;A61K35/76;A61K38/00;A61K39/395;A61K47/36;A61K47/42;A61K47/46;A61K48/00;A61P1/16;A61P9/10;A61P13/12;A61P37/06;A61P43/00;C07K16/40;C12N1/19;C12N1/21;C12N5/10;C12N7/00;C12N9/12;C12N15/09;C12Q1/48;C12R1/01;C12R1/645;C12R1/91;G01N33/15;G01N33/53;G01N33/566;
国家 IL
入库时间 2022-08-21 16:41:36

相似文献

专利
外文文献
中文文献